Share
2,415 Posts.
lightbulb Created with Sketch. 390
clock Created with Sketch.
10/06/17
16:01
Share
Originally posted by lexcorp
↑
You are only one poster ralom. There is plenty more who are seemingly pro cheerleader but constantly remind the wider community of the past and continue to mention the past board and code red which paints a picture of incompetence and continues to paint a bad sentiment.
While they continue to do this along with making the webinar look bad when it wasn't, reminding us of the past board which did well although out of their depth when putting the wrong ppl into sales, the sentiment remains for the time being.
WP coming along wasn't a fluke. It was deliberately done imo and dare I say as I think Eire pointed out, a future CEO may have been already employed. That's if WP decides to move on, which is only speculation in little under 3 years away.
Reminding potential investors of the past is like continuing to throw mud onto something that sticks.
It's digging a hole that they won't get out of earlier
If I stumbled across Ahz the way current holders talk about it on hc I would disregard it and look elsewhere
Especially when I know the only thing that'll change the trend is revenue growing much more than it is and becoming worthwhile on he metrics or more so undervalued on them.
Current holders are doing a disservice to their investment when they think they are doing the opposite.
That's how it is
So I think I can make it happen quicker by deploying capital elsewhere and helping the downramping because cashflow positive is false ATM
All is shown ATM is preservation of capital by the company which is a start
It will take time to penetrate markets and build a brand and awareness with skilled people
Ratty needs to step down and out of the company and stop wasting a board position. He is out of his depth to be blunt
Bennett was one who brought us the med supply business which is keeping cashflow generation high compared to adapt for the time being and us so for a long time
When he stepped down he was hardly mentioned compared to Julian chick. Crazy again by holders to talk chick up in comparison to Bennett imo
I've seen companies so many quarters of positive cashflow.
If they can demonstrate I think 3 or 4 consecutive quarters of positive cashflow then they can apply to report every half after that. And that doesn't mean things are on the up in terms of the sp
The register needs attention big time. An LLC will pump the hell out of it.
Australians are stupid and would rather back a capital intensive miner
I've seen many stocks with big LLC holders see the stock worth way much more. See rva and Emc
When the trend is what it is now the prevailing trend will prevail meantime
It is time the stock gained an American investment house
All imo but food for thought.
If you don't like what i say then that's your problem but I'll be right more than you if you are not being realistic imo
There are stocks doing 50 or $100m revenue and have been doing it longer than Ahz has been but are valued less than Ahz on the market outright such as Lgd and Mbe and there are stocks with bugger all revenue have no niche difference to competitors and have market caps worth more than Ahz
Think about why that is and you will see some common factors such as their register and a lack of mud throwing
Cuv and rva are two prime examples that come to mind and both have LLC involved which pump the hell out of it by bringing in stability to its structure imo
The consolidation hasn't had much benefit to the register either. It needs to be addressed imo
I could be wrong but that's what I reckon so only time will tell
Expand
Hey lex, that is a interesting comment mate .... "The consolidation hasn't had much benefit to the register ...." etc
Not sure what you mean by addressing, what manner of addressing needs to be done mate?
Think as one poster said ages ago (I didn't like the idea of a consolidation at the time) that it was a necessary evil.
I do not believe it was to be a magical cure for the ailments of Admedus but a start.... by tightening up the share registery to be followed, one hopes, by the company receiving the full benefits of the implementation of Code Red.
Hopefully with these two steps followed by great sales figures, revenue and clarification on the direction of the immunotherapies division it will make the company look a lot more "prettier".
Will breathe a sigh of relief if sales do fly off the shelves like 'hot pancakes", still worried that it mightn't happen quick enough.
In a ideal World in ten years or so, If Admedus still the same company, they can start buying their shares back off us ... lol